Pathology of breast cancer in women with constitutional CHEK2 mutations
- 1 March 2005
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 90 (2) , 187-189
- https://doi.org/10.1007/s10549-004-3778-2
Abstract
The power of association studies between polymorphic genetic variants and breast cancer may be enhanced if the cancer subjects are subclassified by histologic subgroup. In this study we classified 482 unselected breast cancers from Szczecin, Poland by histology (ductal, lobular, medullary, other). All women were genotyped for three founder mutations in the CHEK2 gene (1100delC, IVS2 + 1G > A and I157T). There was no significant overall association between CHEK2 and breast cancer (OR = 1.3; p = 0.30), but among those with lobular carcinoma the association with the I157T missense mutation was very strong (OR = 6.6; p > 0.0001). This is the first report to demonstrate that different mutations of the same gene may be associated with specific histologic subtypes of cancer.Keywords
This publication has 6 references indexed in Scilit:
- The 3020insC allele of NOD2 predisposes to early-onset breast cancerBreast Cancer Research and Treatment, 2005
- CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 StudiesAmerican Journal of Human Genetics, 2004
- CHEK2 variant I157T may be associated with increased breast cancer riskInternational Journal of Cancer, 2004
- A Novel Founder CHEK2 Mutation is Associated with Increased Prostate Cancer RiskCancer Research, 2004
- Variants in CHEK2 Other than 1100delC Do Not Make a Major Contribution to Breast Cancer SusceptibilityAmerican Journal of Human Genetics, 2003
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002